US Broker Ratings

Clover Health Investments (CLOV): Analyzing Its 34.72% Potential Upside and Revenue Surge

Clover Health Investments, Corp (NASDAQ: CLOV), a key player in the healthcare plans sector, presents a captivating prospect for investors with its compelling 34.72% potential upside...

Novavax, Inc. (NVAX) Stock Analysis: Exploring a Potential 91% Upside in the Biotech Arena

Novavax, Inc. (NVAX), a prominent player in the biotechnology sector, is making headlines with a potential upside of 91.05%, according to analyst consensus. Known for its..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands out in the healthcare sector with a specialized focus on non-opioid pain management solutions. With its current market cap at..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Uncovering a 19.81% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a notable player in the healthcare sector, specifically within the drug manufacturing industry, is attracting significant attention from investors due to..

MiMedx Group, Inc (MDXG) Stock Analysis: A 79.94% Potential Upside in the Biotechnology Sector

MiMedx Group, Inc. (NASDAQ: MDXG), a promising entity within the healthcare sector, particularly the biotechnology industry, has caught the attention of investors with its significant growth..

agilon health, inc. (AGL) Stock Analysis: Navigating a Challenging Healthcare Landscape with a 57% Upside Potential

agilon health, inc. (NYSE: AGL), a key player in the healthcare sector, is navigating a complex landscape filled with both challenges and opportunities. With a market..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 68% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE), a pioneering company in the realm of bioelectric medicine, stands at a crucial intersection of innovation and market potential. Headquartered in..

Adaptive Biotechnologies (ADPT) Stock Analysis: Unveiling Growth Potential Amid a Robust Healthcare Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a prominent player in the biotechnology industry, has garnered significant investor attention due to its innovative approach in the healthcare sector...

Indivior PLC (INDV) Investor Outlook: Buy Ratings and 11.32% Potential Upside Highlight Growth Opportunities

Indivior PLC (INDV) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Its market capitalization of $4.12..

Opko Health, Inc. (OPK) Stock Analysis: Unpacking a 173.72% Potential Upside Amid Challenging Financials

Opko Health, Inc. (NASDAQ: OPK), a player in the healthcare sector with a focus on diagnostics and pharmaceuticals, presents a compelling case for investors looking at..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 15.59% Potential Upside Amid Growth Prospects

Healthcare Services Group, Inc. (NASDAQ: HCSG), a significant player in the healthcare support services sector, stands out not only for its robust market presence but also..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Biotech Powerhouse with a 16.49% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the biotechnology sector with its focus on addressing diseases driven by dysregulated aldosterone. With a market capitalization..

Kestra Medical Technologies, Ltd (KMTS) Stock Analysis: A High-Growth Opportunity in Healthcare Innovation

Kestra Medical Technologies, Ltd (KMTS), a promising player in the healthcare sector, has been gaining traction among investors due to its innovative approach in the medical..

Ligand Pharmaceuticals (LGND) Stock Analysis: Unpacking a 14.8% Potential Upside in the Biotech Sector

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is emerging as a compelling player in the biotechnology sector, with a promising 14.8% potential upside according to recent analyst ratings...

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Explosive Growth Potential with 24.64% Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, is catching the attention of investors with its innovative approach to tackling intractable diseases...

Organon & Co. (OGN) Stock Analysis: Navigating a 36.92% Potential Upside Amid Market Challenges

In the dynamic landscape of the healthcare sector, Organon & Co. (NYSE: OGN) stands as a distinctive player, focusing on prescription therapies and medical devices with..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: A Promising 28.66% Upside Potential

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) has been making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring 13.41% Potential Upside in the Healthcare Diagnostics Arena

For investors seeking opportunities within the healthcare sector, NeoGenomics, Inc. (NASDAQ: NEO) presents an intriguing proposition. As a prominent player in the diagnostics and research industry,..

Neogen Corporation (NEOG) Investor Outlook: Potential Upside of 39.36% Amidst Healthcare Sector Challenges

Neogen Corporation (NEOG), a notable player in the healthcare sector within the diagnostics and research industry, presents an intriguing case for investors seeking a blend of..

Guardian Pharmacy Services, Inc (GRDN): Growth Potential with 18.55% Upside

Guardian Pharmacy Services, Inc. (GRDN), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on providing specialized pharmacy services to..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds